Commonwealth Equity Services
AURA icon

Commonwealth Equity Services’s Aura Biosciences AURA Stock Holding History

Commonwealth Equity Services’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$203K Hold
30,284
– – ﹤0.01% 3997
2025
Q4 		$165K Sell
30,284
-568
-2% -$3.37K ﹤0.01% 4028
2025
Q3 		$191K Sell
30,852
-105
-0.3% -$687 ﹤0.01% 3959
2025
Q2 		$194K Buy
30,957
+679
+2% +$3.97K ﹤0.01% 3930
2025
Q1 		$177K Buy
30,278
+278
+0.9% +$2.1K ﹤0.01% 3871
2024
Q4 		$247K Hold
30,000
– – ﹤0.01% 3584
2024
Q3 		$267K Buy
30,000
+5,000
+20% +$42.9K ﹤0.01% 3452
2024
Q2 		$189K Buy
+25,000
New +$183K ﹤0.01% 3656

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Commonwealth Equity Services's AURA Position: Q1 2026 in Review

Commonwealth Equity Services held its Aura Biosciences (AURA) position steady in Q1 2026 at 30,284 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #3997.

Commonwealth Equity Services first reported a position in AURA in Q2 2024 and has held it in 8 quarters since. The position peaked at $267K in Q3 2024. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Commonwealth Equity Services held 30,284 shares of Aura Biosciences worth $203K as of Q1 2026.
  • Commonwealth Equity Services left its Aura Biosciences share count unchanged in Q1 2026.
  • Aura Biosciences made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #3997 holding.
  • Commonwealth Equity Services first reported a position in Aura Biosciences in Q2 2024 and has held it in 8 quarters since.
  • Commonwealth Equity Services's Aura Biosciences position peaked at $267K in Q3 2024.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.